Worcester HIV Vaccine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2018-01-01
- Employees
- 1
- Market Cap
- -
- Website
- https://www.whvaccine.com
Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected Adults
Phase 1
Completed
- Conditions
- HIV Infections
- Interventions
- Biological: PlaceboBiological: env (A,B,C,A/E)/gag (C) DNA VaccineBiological: gp120 (A,B,C,A/E) Protein VaccineBiological: GLA-SE adjuvant
- First Posted Date
- 2021-06-16
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Worcester HIV Vaccine
- Target Recruit Count
- 42
- Registration Number
- NCT04927585
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath